プレス

プレスコVERAGE

評価する企業に関するヘッドライン。公的なニュースソースから集められ、元の記事へのリンクを提供します。感動タグはキーワードに基づいており、編集判断ではありません。

以下のカバー範囲を表示しています Galderma

26件のヘッドライン · 1,721件の企業カバー

1～26 / 26件

2026-10-16
Cetaphil Maker Galderma to Buy ZO Skin Health for $1.5 Billion in Medical Skincare Push - Law Commentary
Galderma· www.lawcommentary.com
2026-10-15
Galderma buys ZO Skin Health for US$1.5B to expand dermatological skin care - Personal Care Insights
Galderma· www.personalcareinsights.com
2026-10-15
Galderma to snap up California-based ZO Skin Health for USD 1.5 billion - Premium Beauty News
Galderma· www.premiumbeautynews.com
2026-10-15
Galderma to Acquire ZO Skin Health for $1.5 Billion - WWD
Galderma· wwd.com
2026-10-15
PeDRA 2026: Nemolizumab Phase II Data Show Long-Term Symptom Relief for Children Aged 2 to 11 Years With Moderate-to-Severe Atopic Dermatitis
Galderma· finance.yahoo.com
2026-10-14
Galderma bulks up dermatology portfolio with $1.5B acquisition of Zo Skin Health - Fierce Pharma
Galderma· www.fiercepharma.com
2026-10-14
Galderma to buy US firm ZO Skin Health for $1.5 billion - Reuters
Galderma· www.reuters.com
2026-10-14
Galderma to Buy ZO Skin Health for $1.5 Billion - WSJ
Galderma· www.wsj.com
2026-10-14
Galderma Signs Agreement to Acquire ZO Skin Health, Strengthening Its Physician-Dispensed Skincare Offering
Galderma· finance.yahoo.com
2026-10-14
Galderma Signs Agreement to Acquire ZO Skin Health, Strengthening Its Physician-Dispensed Skincare Offering - Business Wire
Galderma· www.businesswire.com
2026-10-14
Galderma to buy Blackstone-owned ZO Skin Health for $1.5 bln
Galderma· finance.yahoo.com
2026-10-13
New Galderma Research Reveals More Than Half of Women Mistake Menopause-Related Skin Changes for Signs of Ageing
Galderma· finance.yahoo.com
2026-10-08
Fall Clinical 2026: Galderma Presents New Three-Year Nemluvio® Data Showing Deep and Lasting Skin Lesion and Itch Responses in Patients With Atopic Dermatitis Aged 12 and Older
Galderma· finance.yahoo.com
2026-10-06
30 Years of Restylane®: Reshaping the Aesthetics Field Through Science-Led, Patient-Centric Innovation
Galderma· finance.yahoo.com
2026-09-30
EADV 2026: Galderma’s New Data Show Sustained Improvements with Nemluvio® (nemolizumab) for up to Three Years in Patients With Moderate-to-severe Atopic Dermatitis
Galderma· finance.yahoo.com
2026-09-23
EADV 2026: Galderma to Unveil New Data Advancing Understanding of Skin Diseases, Skin Longevity, and Real-world Patient Experiences
Galderma· finance.yahoo.com
2026-09-22
Why Galderma Group (SWX:GALD) Is Getting Attention Today
Galderma· finance.yahoo.com
2026-09-21
Galderma Begins Trading in the Swiss Market Index, Joining Switzerland's Leading Blue Chip Companies
Galderma· finance.yahoo.com
2026-09-16
Galderma’s Restylane® Volyme™ Demonstrates High Effectiveness, Satisfaction and a Robust Safety Profile in Chinese Patients With Temple Hollowing
Galderma· finance.yahoo.com
2026-09-08
Plastic surgery is booming with boomers. Here’s how to cash in on the antiaging craze.
Galderma· marketwatch.com
2026-08-11
Galderma Receives European Union Approval for Restylane® Shaype™: the First-and-Only Bone-Mimicking Hyaluronic Acid Injectable for Facial Shaping
Galderma· finance.yahoo.com
2026-07-30
Morgan Stanley bullish on Galderma on stronger Nemluvio growth outlook
Galderma· finance.yahoo.com
2026-07-23
Galderma Group AG (GDERF) Half Year 2026 Earnings Call Highlights: Record Sales and Strategic ...
Galderma· finance.yahoo.com
2026-07-23
Galderma Reports Record First Half 2026 Net Sales of 3.134 Billion USD and 24.6% Year-on-Year Growth at Constant Currency, Raises Net Sales Guidance for the Full Year
Galderma· finance.yahoo.com
2026-07-20
Galderma Launches Alastin® in Japan and Key Markets Across Asia Pacific, Expanding Its Footprint in the Region
Galderma· finance.yahoo.com
2026-07-07
Landmark Global Galderma Survey Shows 9 out of 10 People Are Affected by Skin Quality Concerns
Galderma· finance.yahoo.com